Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Ephrin Receptor
    (7)
  • c-Kit
    (3)
  • Bcr-Abl
    (2)
  • Raf
    (2)
  • Src
    (2)
  • c-RET
    (2)
  • Anti-infection
    (1)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Others
    (4)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FACS
    (1)
  • Functional assay
    (1)
Filter
Search Result
Results for "

epha-2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    11
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Recombinant Protein
    10
    TargetMol | Recombinant_Protein
  • Antibody Products
    16
    TargetMol | Antibody_Products
UniPR505
T733682938227-14-4In house
UniPR505 is a potent EphA2 antagonist (IC50: 0.95 µM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.
  • $518
In Stock
Size
QTY
Dasatinib monohydrate
BMS-354825 Monohydrate
T1448L863127-77-9
Dasatinib monohydrate (BMS-354825 Monohydrate) is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib monohydrate binds to and inhibits the growth-promoting activities of these kinases. Apparently, because of its less stringent binding affinity for the BCR-ABL kinase, Dasatinib monohydrate has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
Agerafenib hydrochloride
RXDX-105 hydrochloride, CEP-32496 (hydrochloride)
T149281227678-26-3
Agerafenib hydrochloride, a highly potent inhibitor of BRAFV600E (Kd: 14 nM), demonstrates significant efficacy.
  • $1,670
8-10 weeks
Size
QTY
NVP-BHG712 isomer
T194872245892-85-5
NVP-BHG712 isomer shows conserved non-bonded binding to EPHA2 and EPHB4.
  • $36
In Stock
Size
QTY
EphA2 agonist 2
T727652169273-66-7
EphA2 agonist 2 (Lead compound) is a selective agonist targeting the EphA2 receptor, with antitumor properties and the ability to cross the blood-brain barrier (BBB).
  • $1,520
6-8 weeks
Size
QTY
EphA2 agonist 1
T746112611459-57-3
EphA2 Agonist 1 (Compound 7bg) is a potent and selective EphA2 receptor agonist, demonstrating significant efficacy in targeting overexpressed EphA2 glioblastoma cells and inducing EphA2 phosphorylation [1].
  • Inquiry Price
Inquiry
Size
QTY
EPHA2/A4/GAK-IN-1
T88939
EPHA2/A4/GAK-IN-1 (compound 55) is a potent inhibitor of EPHA2, EPHA4, and GAK, exhibiting KD values of 180.5 nM for EPHA2 and 19.2 nM for GAK, respectively. The predicted half-life of EPHA2/A4/GAK-IN-1 in microsomal stability tests measures 4.6 hours. Additionally, this compound has antiviral efficacy, capable of preventing Dengue virus infection in Huh7 hepatocytes.
  • Inquiry Price
Inquiry
Size
QTY
Anti-EphA2 Antibody
T9901A-1410
Anti-EphA2 Antibody is a human-derived antibody expressed in CHO cells, specifically targeting EphA2. Its predicted molecular weight (MW) is 150 kDa. For isotype control, refer to Human IgG1 kappa, Isotype Control.
    Inquiry
    Agerafenib
    RXDX-105, CEP-32496, CEP32496, CEP 32496
    T20701188910-76-0
    Agerafenib (CEP32496) is a highly potent inhibitor of BRAF.
    • $35
    In Stock
    Size
    QTY
    UniPR129
    Uni-PR-129, Uni PR 129
    T263101639159-47-9
    UniPR129 is a competitive Eph-ephrin antagonist agent that acts by blocking in vitro angiogenesis at low micromolar concentrations.
    • $916
    6-8 weeks
    Size
    QTY
    NG25
    T56431315355-93-1
    NG25 is a potent dual inhibitor of TAK1 and MAP4K2, with IC50s of 149 nM and 21.7 nM, respectively.
    • $79
    In Stock
    Size
    QTY
    TargetMol | Citations Cited